Novel crystalline compound useful as GLK activator

Details for Australian Patent Application No. 2007336016 (hide)

Owner AstraZeneca AB

Inventors Tomkinson, Gary Peter; McCabe, James

Agent Davies Collison Cave

Pub. Number AU-A-2007336016

PCT Pub. Number WO2008/075073

Priority 60/871,255 21.12.06 US

Filing date 20 December 2007

Wipo publication date 26 June 2008

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 July 2009 PCT application entered the National Phase

  PCT publication WO2008/075073 Priority application(s): WO2008/075073

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336023-Device and method for producing therapeutic foam

2007336014-A jig for cutting a brick or bricks